Image Description (Figure 1)
Truxima Injection, Solution
Product Images NDC 63459-103
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Truxima (NDC 63459-103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cephalon, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel (100mg Vial Carton)
This is a chart that displays the percentage of ACR 20 responders over time for two groups of patients: one treated with placebo (n=201) and the other treated with Rituximab 2x1000mg (n=298). The chart shows that after 20 weeks, 100% of the patients in the Rituximab group were ACR 20 responders, while only 20% of the patients in the placebo group achieved the same response. The chart also shows that at 10 weeks, the percentage of responders was lower in both groups.*
Principal Display Panel (500 mg Vial Carton)
Figure 4
Truxima is a medication that comes in the form of an injection for intravenous use after dilution, contained in a single-dose vial. The medication contains rituximab-abbs, with a strength of 10 mg/mL. It is important for the pharmacist to provide the enclosed medication guide to the patient. No additional information is available.*
Figure 5
Truxima is an intravenous medication containing rituximab-abbs used in the treatment of certain medical conditions. It comes in a single-dose vial with 500mg/50mL strength and should only be administered after dilution. Any unused portion should be discarded. Pharmacists are advised to provide the enclosed medication guide to the patient. This medication requires a prescription.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
